Cargando…

ECMO support for COVID-19: a balancing act – Authors' reply

Detalles Bibliográficos
Autores principales:	Barbaro, Ryan P, MacLaren, Graeme, Brodie, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832424/ https://www.ncbi.nlm.nih.gov/pubmed/33422256 http://dx.doi.org/10.1016/S0140-6736(20)32517-4

Ejemplares similares

COVID-19 ARDS: getting ventilation right – Authors' reply
por: Barbaro, Ryan P, et al.
Publicado: (2022)

Blood transfusion strategies and ECMO during the COVID-19 pandemic – Authors' reply
por: Ramanathan, Kollengode, et al.
Publicado: (2020)

What’s new in ECMO for COVID-19?
por: MacLaren, Graeme, et al.
Publicado: (2020)

Outcomes after extracorporeal life support for COVID-19 myocarditis: an analysis of the Extracorporeal Life Support Organization Registry
por: Tonna, Joseph E., et al.
Publicado: (2022)

ECMO support for COVID-19: a balancing act
por: Zhang, Yang, et al.
Publicado: (2021)

Determinants of long-term outcomes in patients with COVID-19 supported with ECMO – Authors' reply
por: Lorusso, Roberto, et al.
Publicado: (2023)

Cytokine adsorption and ECMO in patients with COVID-19 – Author's reply
por: Supady, Alexander
Publicado: (2021)

When to initiate ECMO with low likelihood of success
por: MacLaren, Graeme
Publicado: (2018)

Expanding controlled donation after the circulatory determination of death: stronger emphasis on different cultural, religious and legal backgrounds is needed
por: Müller, Thomas, et al.
Publicado: (2021)

Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases
por: Ramanathan, Kollengode, et al.
Publicado: (2020)

COVID-19 research in LMICs – Authors' reply
por: Torres, Irene, et al.
Publicado: (2021)

Cancer and COVID-19 – Authors' reply
por: Kuderer, Nicole M, et al.
Publicado: (2020)

Remdesivir and COVID-19 – Authors' reply
por: Wang, Yeming, et al.
Publicado: (2020)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

COVID-19 in patients with HIV – Authors' reply
por: Miró, José M, et al.
Publicado: (2020)

COVID-19 and preterm birth – Authors' reply
por: Choudhary, Rahul, et al.
Publicado: (2021)

Neuropsychiatric disorders and COVID-19 – Authors' reply
por: Taquet, Maxime, et al.
Publicado: (2021)

COVID-19 and myocardial infarction – Authors' reply
por: Katsoularis, Ioannis, et al.
Publicado: (2021)

Fluvoxamine for the treatment of COVID-19 – Author's reply
por: Reis, Gilmar, et al.
Publicado: (2022)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

Determinants of long-term outcomes in patients with COVID-19 supported with ECMO
por: Guervilly, Christophe, et al.
Publicado: (2023)

Frailty and mortality in patients with COVID-19 – Authors' reply
por: McCarthy, Kathryn, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19 – Authors' reply
por: Hayem, Gilles, et al.
Publicado: (2020)

Psychiatric and neuropsychiatric syndromes and COVID-19 – Authors' reply
por: Rogers, Jonathan P, et al.
Publicado: (2020)

Management of diabetes in patients with COVID-19 – Authors' reply
por: Bornstein, Stefan R, et al.
Publicado: (2020)

COVID-19: from hospitals to courts – Author's reply
por: Usuelli, Michele
Publicado: (2021)

Surgery during the COVID-19 pandemic – Authors' reply
por: COVIDSurg Collaborative
Publicado: (2020)

Azithromycin for mild-to-moderate COVID-19 – Authors' reply
por: Hinks, Timothy S C
Publicado: (2021)

Antipsychotics and COVID-19: the debate goes on – Authors' reply
por: De Picker, Livia, et al.
Publicado: (2021)

Depression and anxiety during COVID-19 – Authors' reply
por: Santomauro, Damian F, et al.
Publicado: (2022)

WHO COVID-19 therapeutic guidelines – Authors' reply
por: White, Nicholas J, et al.
Publicado: (2021)

COVID-19 and global mental health – Authors' reply
por: Kola, Lola, et al.
Publicado: (2021)

COVID-19 and maternal and perinatal outcomes – Authors' reply
por: Chmielewska, Barbara, et al.
Publicado: (2021)

Combining immunomodulators and antivirals for COVID-19 – Authors' reply
por: Almansa, Raquel, et al.
Publicado: (2021)

Assessing the importance of interleukin-6 in COVID-19 – Authors' reply
por: Leisman, Daniel E, et al.
Publicado: (2021)

Authors' Reply
por: Bush, Eliot C, et al.
Publicado: (2006)

Author's Reply
por: Kaeberlein, Matt, et al.
Publicado: (2006)

Authors' Reply
por: van Nimwegen, Erik, et al.
Publicado: (2006)

Authors' Reply
por: Nguyen, Hung D, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ofvtf9fvgpnf2n0nk18aatkgdt